类风湿性关节炎
医学
免疫学
癌症研究
滑膜
病理
作者
Elena Neumann,Stephanie Lefèvre,Birgit Zimmermann,Steffen Gay,Ulf Müller‐Ladner
标识
DOI:10.1016/j.molmed.2010.07.004
摘要
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial hyperplasia and progressive joint destruction. Rheumatoid arthritis synovial fibroblasts (RASFs) are leading cells in joint erosion and contribute actively to inflammation. RASFs show an activated phenotype that is independent of the inflammatory environment and requires the combination of several factors. Although new aspects regarding RASF activation via matrix degradation products, epigenetic modifications, inflammatory factors, Toll-like receptor (TLR) activation and others have recently been uncovered, the primary pathophysiological processes in early arthritis leading to permanent activation are mostly unknown. Here, we review new findings regarding RASF activation and their altered behavior that contribute to matrix destruction and inflammation as well as their potential to spread RA. Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial hyperplasia and progressive joint destruction. Rheumatoid arthritis synovial fibroblasts (RASFs) are leading cells in joint erosion and contribute actively to inflammation. RASFs show an activated phenotype that is independent of the inflammatory environment and requires the combination of several factors. Although new aspects regarding RASF activation via matrix degradation products, epigenetic modifications, inflammatory factors, Toll-like receptor (TLR) activation and others have recently been uncovered, the primary pathophysiological processes in early arthritis leading to permanent activation are mostly unknown. Here, we review new findings regarding RASF activation and their altered behavior that contribute to matrix destruction and inflammation as well as their potential to spread RA. Erratum to “Rheumatoid arthritis progression mediated by activated synovial fibroblasts” [Trends in Molecular Medicine 16 (2010) 10]Neumann et al.Trends in Molecular MedicineFebruary 3, 2011In BriefThe authors regret that an error has occurred in this paper. Owing to the required shortening and editing of our review, the meaning of one citation was changed. We apologize for the error and would like to change the following statement regarding citation [27]:Incorrect statement within the review: Full-Text PDF
科研通智能强力驱动
Strongly Powered by AbleSci AI